The NIH Somatic Cell Genome Editing program
Krishanu Saha, Erik J. Sontheimer, Philip John Brooks et al. · Nature · 2021
The move from reading to writing the human genome offers new opportunities to improve human health. The United States National Institutes of Health (NIH) Somatic Cell Genome Editing (SCGE) Consortium aims to accelerate the development of safer and more-effective methods to edit the genomes of disease-relevant somatic cells in patients, even in tissues that are difficult to reach. Here we discuss the consortium's plans to develop and benchmark approaches to induce and measure genome modifications, and to define downstream functional consequences of genome editing within human cells. Central to this effort is a rigorous and innovative approach that requires validation of the technology through third-party testing in small and large animals. New genome editors, delivery technologies and methods for tracking edited cells in vivo, as well as newly developed animal models and human biological systems, will be assembled-along with validated datasets-into an SCGE Toolkit, which will be disseminated widely to the biomedical research community. We visualize this toolkit-and the knowledge generated by its applications-as a means to accelerate the clinical development of new therapies for a wide range of conditions.
Cited by 125 works. doi:10.1038/s41586-021-03191-1 Open-access PDF
Authors
- Krishanu Saha
- Erik J. Sontheimer
- Philip John Brooks
- Melinda R. Dwinell
- Charles A. Gersbach
- David R. Liu
- Stephen A. Murray
- Shengdar Q. Tsai
- Ross C. Wilson
- Daniel G. Anderson
- Aravind Asokan
- Jillian F. Banfield
- Krystof S. Bankiewicz
- Gang Bao
- Jeff W. M. Bulte
- Nenad Bursac
- Jarryd M. Campbell
- Daniel F. Carlson
- Elliot L. Chaikof
- Zheng‐Yi Chen
References
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- RNA-Guided Human Genome Engineering via Cas9
- The ENCODE (ENCyclopedia Of DNA Elements) Project
- Efficient genome editing in zebrafish using a CRISPR-Cas system
- A TALE nuclease architecture for efficient genome editing
- RNA-guided editing of bacterial genomes using CRISPR-Cas systems
- Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
- A New Five-Year Plan for the U.S. Human Genome Project
- RNA-programmed genome editing in human cells